Structurally related (-)-epicatechin metabolites in humans: Assessment using de novo chemically synthesized authentic standards

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1403-1412

  Ottaviani, Javier I ^a   Momma, Tony Y ^a   Kuhnle, Gunter K ^b   Keen, Carl L ^a,c   Schroeter, Hagen ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MARS INC   (United States)

Author keywords

Cocoa; Flavanols; Flavonoids; Metabolism; Polyphenols; Procyanidins

Indexed keywords

3' O ETHYLEPICATECHIN; 3' O METHYLEPICATECHIN; 3' O METHYLEPICATECHIN 5 SULFATE; 3' O METHYLEPICATECHIN 7 BETA DEXTRO GLUCURONIDE; 3' O METHYLEPICATECHIN 7 SULFATE; 4' O METHYLEPICATECHIN; 4' O METHYLEPICATECHIN 3' BETA DEXTRO GLUCURONIDE; 4' O METHYLEPICATECHIN 5 BETA DEXTRO GLUCURONIDE; 4' O METHYLEPICATECHIN 7 BETA DEXTRO GLUCURONIDE; EPICATECHIN; EPICATECHIN 3' BETA DEXTRO GLUCURONIDE; EPICATECHIN 3' DEXTRO GLUCURONIDE; EPICATECHIN 3' SULFATE; EPICATECHIN 5 SULFATE; EPICATECHIN 7 SULFATE; EPICATECHIN DERIVATIVE; FLAVANOL DERIVATIVE; GLUCURONIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CARBON NUCLEAR MAGNETIC RESONANCE; DIETARY INTAKE; ELECTROCHEMICAL DETECTION; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; MALE; METABOLITE; NORMAL HUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE EXTRACTION; STEREOCHEMISTRY; SULFONATION; TANDEM MASS SPECTROMETRY; ULTRAVIOLET SPECTROSCOPY;

ADOLESCENT; ADULT; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

MAMMALIA; THEOBROMA CACAO;

EID: 84859010162     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.12.010     Document Type: Article

References (43)

1. Neveu, V.; Perez-Jiménez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.;Mennen, L.; Knox, C.; Eisner, R.; Cruz, J.;Wishart, D.; Scalbert, A. Phenol-Explorer: an online comprehensive database on polyphenol contents in foodsAccessed on 5 May 2010. Database version 1.5.2, available at http://www.phenol-explorer.eu; 2010.
2. USDA database for the proanthocyanidin content of selected foods. Accessed on 28 April 2010. Available at http://www.nal.usda.gov/fnic/foodcomp/ Data/PA/PA.html; 2004.
3. USDA database for the flavonoid content of selected foods, release 2.1. Accessed on 8 December 2010. Available at http://www.nal.usda.gov/fnic/foodcomp/ Data/Flav/Flav02-1.pdf; 2007.
4. McCullough, M. L.; Chevaux, K.; Jackson, L.; Preston, M.; Martinez, G.; Schmitz, H. H.; Coletti, C.; Campos, H.; Hollenberg, N. K. Hypertension, the Kuna, and the epidemiology of flavanols. J. Cardiovasc. Pharmacol. 47 (Suppl. 2):S103-S109 discussion 119-121; 2006.
5. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81:317S-325S; 2005.
6. Mink, P. J.; Scrafford, C. G.; Barraj, L. M.; Harnack, L.; Hong, C. P.; Nettleton, J. A.; Jacobs Jr., D. R. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 85:895-909; 2007.
7. Mursu, J.; Voutilainen, S.; Nurmi, T.; Tuomainen, T. P.; Kurl, S.; Salonen, J. T. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br. J. Nutr. 100: 890-895; 2008.
8. Flammer, A. J.; Hermann, F.; Sudano, I.; Spieker, L.; Hermann, M.; Cooper, K. A.; Serafini, M.; Luscher, T. F.; Ruschitzka, F.; Noll, G.; Corti, R. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 116:2376-2382; 2007.
9. Heiss, C.; Finis, D.; Kleinbongard, P.; Hoffmann, A.; Rassaf, T.; Kelm, M.; Sies, H. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J. Cardiovasc. Pharmacol. 49:74-80; 2007.
10. Heiss, C.; Jahn, S.; Taylor, M.; Real, W. M.; Angeli, F. S.; Wong, M. L.; Amabile, N.; Prasad,M.; Rassaf, T.; Ottaviani, J. I.;Mihardja, S.; Keen, C. L.; Springer, M. L.; Boyle, A.; Grossman, W.; Glantz, S. A.; Schroeter, H.; Yeghiazarians, Y. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J. Am. Coll. Cardiol. 56:218-224; 2010.
11. Holt, R. R.; Schramm, D. D.; Keen, C. L.; Lazarus, S. A.; Schmitz, H. H. Chocolate consumption and platelet function. JAMA 287:2212-2213; 2002.
12. Taubert, D.; Roesen, R.; Lehmann, C.; Jung, N.; Schomig, E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298:49-60; 2007.
13. Balzer, J.; Rassaf, T.;Heiss, C.; Kleinbongard, P.; Lauer, T.;Merx,M.; Heussen, N.; Gross, H. B.; Keen, C. L.; Schroeter, H.; Kelm, M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients: a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol. 51:2141-2149; 2008.
14. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des. 15:1072-1084; 2009.
15. Hollenberg, N. K.; Fisher, N. D.; McCullough, M. L. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J. Am. Soc. Hypertens. 3:105-112; 2009.
16. Loke, W. M.; Hodgson, J. M.; Proudfoot, J. M.; McKinley, A. J.; Puddey, I. B.; Croft, K. D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr. 88:1018-1025; 2008.
17. Schroeter, H.;Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C. L.; Hollenberg, N. K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H. H.; Kelm, M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. U. S. A. 103:1024-1029; 2006.
18. Schroeter, H.; Heiss, C.; Spencer, J. P.; Keen, C. L.; Lupton, J. R.; Schmitz, H. H. Recommending flavanols and procyanidins for cardiovascular health: current knowledge and future needs. Mol. Aspects Med. 31:546-557; 2010.
19. Heiss, C.; Keen, C. L.; Kelm, M. Flavanols and cardiovascular disease prevention. Eur. Heart J. 31:2583-2592; 2010.
20. Baba, S.; Osakabe, N.; Yasuda, A.; Natsume, M.; Takizawa, T.; Nakamura, T.; Terao, J. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic. Res. 33:635-641; 2000.
21. Natsume, M.; Osakabe, N.; Oyama, M.; Sasaki, M.; Baba, S.; Nakamura, Y.; Osawa, T.; Terao, J. Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic. Biol. Med. 34:840-849; 2003.
22. Heiss, C.; Kleinbongard, P.; Dejam, A.; Perre, S.; Schroeter, H.; Sies, H.; Kelm,M. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J. Am. Coll. Cardiol. 46:1276-1283; 2005.
23. Auger, C.; Mullen, W.; Hara, Y.; Crozier, A. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. J. Nutr. 138:1535S-1542S; 2008.
24. Mullen, W.; Borges, G.; Donovan, J. L.; Edwards, C. A.; Serafini, M.; Lean, M. E.; Crozier, A. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am. J. Clin. Nutr. 89:1784-1791; 2009.
25. Piskula, M. K.; Terao, J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128:1172-1178; 1998.
26. Spencer, J. P.; Chowrimootoo, G.; Choudhury, R.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 458:224-230; 1999.
27. Kuhnle, G.; Spencer, J. P.; Schroeter, H.; Shenoy, B.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. 277:507-512; 2000.
28. Donovan, J. L.; Crespy, V.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A.; Remesy, C. Catechin is metabolized by both the small intestine and liver of rats. J. Nutr. 131:1753-1757; 2001.
29. Zimmermann, B. F.; Papagiannopoulos, M.; Brachmann, S.; Lorenz, M.; Stangl, V.; Galensa, R. A shortcut from plasma to chromatographic analysis: straightforward and fast sample preparation for analysis of green tea catechins in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877:823-826; 2009.
30. Baba, S.; Osakabe, N.; Natsume, M.; Muto, Y.; Takizawa, T.; Terao, J. Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J. Agric. Food Chem. 49:6050-6056; 2001.
31. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Identification of (-)- epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos. 27:309-316; 1999.
32. Unno, T.; Sagesaka, Y. M.; Kakuda, T. Analysis of tea catechins in human plasma by high-performance liquid chromatography with solid-phase extraction. J. Agric. Food Chem. 53:9885-9889; 2005.
33. Roura, E.; Andres-Lacueva, C.; Jauregui, O.; Badia, E.; Estruch, R.; Izquierdo-Pulido, M.; Lamuela-Raventos, R. M. Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma (-)-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J. Agric. Food Chem. 53: 6190-6194; 2005.
34. Donovan, J. L.; Luthria, D. L.; Stremple, P.;Waterhouse, A. L. Analysis of (+)-catechin, (-)-epicatechin and their 3′- and 4′-O-methylated analogs: a comparison of sensitive methods. J. Chromatogr. B Biomed. Sci. Appl. 726:277-283; 1999.
35. Ottaviani, J. I.; Momma, T. Y.; Heiss, C.; Kwik-Uribe, C.; Schroeter, H.; Keen, C. L. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic. Biol. Med. 50:237-244; 2011.
36. Robbins, R. J.; Leonczak, J.; Johnson, J. C.; Li, J.; Kwik-Uribe, C.; Prior, R. L.; Gu, L. Method performance and multi-laboratory assessment of a normal phase high pressure liquid chromatography-fluorescence detection method for the quantitation of flavanols and procyanidins in cocoa and chocolate containing samples. J. Chromatogr. A 1216:4831-4840; 2009.
37. Vaidyanathan, J. B.; Walle, T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 30:897-903; 2002.
38. Stalmach, A.; Mullen, W.; Steiling, H.; Williamson, G.; Lean, M. E.; Crozier, A. Absorption,metabolism, and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res. 53 (Suppl. 1):S44-S53; 2009.
39. Mannisto, P. T.; Kaakkola, S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51:593-628; 1999.
40. Harada, M.; Kan, Y.; Naoki, H.; Fukui, Y.; Kageyama, N.; Nakai, M.; Miki, W.; Kiso, Y. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci. Biotechnol. Biochem. 63:973-977; 1999.
41. Weitering, J. G.; Krijgsheld, K. R.; Mulder, G. J. The availability of inorganic sulphate as a rate limiting factor in the sulphate conjugation of xenobiotics in the rat? Sulphation and glucuronidation of phenol. Biochem. Pharmacol. 28:757-762; 1979.
42. Koster, H.; Halsema, I.; Scholtens, E.; Knippers, M.; Mulder, G. J. Dose-dependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes: the role of saturation of phenolsulfotransferase. Biochem. Pharmacol. 30:2569-2575; 1981.
43. Bors, W.; Michel, C.; Stettmaier, K. Structure-activity relationships governing antioxidant capacities of plant polyphenols. Methods Enzymol. 335:166-180; 2001.